Search research articles
Contact Us
Filters
Showing results (111-120 of 116) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 116 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer
Andrew E Hendifar, Viswesh Krishna, Vrishab Krishna, et al.
Neuron
|
March 13, 2025
Role of clonal inflammatory microglia in histiocytosis-associated neurodegeneration
Rocio Vicario, Stamatina Fragkogianni, Maria Pokrovskii, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2024
Mechanism of neurodegeneration mediated by clonal inflammatory microglia
Rocio Vicario, Stamatina Fragkogianni, Maria Pokrovskii, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer
Wungki Park, Shigeaki Umeda, Marc Hilmi, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature Medicine
|
March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Wungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 116) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 116 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer
Andrew E Hendifar, Viswesh Krishna, Vrishab Krishna, et al.
Neuron
|
March 13, 2025
Role of clonal inflammatory microglia in histiocytosis-associated neurodegeneration
Rocio Vicario, Stamatina Fragkogianni, Maria Pokrovskii, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2024
Mechanism of neurodegeneration mediated by clonal inflammatory microglia
Rocio Vicario, Stamatina Fragkogianni, Maria Pokrovskii, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer
Wungki Park, Shigeaki Umeda, Marc Hilmi, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
Nature Medicine
|
March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Wungki Park, Catherine A O'Connor, Joanne F Chou, et al.
Page
of 12